Combination therapy for relapsed peripheral T-cell lymphoma: is two better than one?

被引:2
作者
Bachy, Emmanuel [1 ]
Coiffier, Bertrand [1 ]
机构
[1] Ctr Hosp Lyon Sud, Dept Hematol, F-69310 Pierre Benite, France
关键词
PHASE-II; PROTEASOME;
D O I
10.1016/S2352-3026(15)00116-7
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:E307 / E308
页数:2
相关论文
共 10 条
[1]   Results From a Pivotal, Open-Label, Phase II Study of Romidepsin in Relapsed or Refractory Peripheral T-Cell Lymphoma After Prior Systemic Therapy [J].
Coiffier, Bertrand ;
Pro, Barbara ;
Prince, H. Miles ;
Foss, Francine ;
Sokol, Lubomir ;
Greenwood, Matthew ;
Caballero, Dolores ;
Borchmann, Peter ;
Morschhauser, Franck ;
Wilhelm, Martin ;
Pinter-Brown, Lauren ;
Padmanabhan, Swaminathan ;
Shustov, Andrei ;
Nichols, Jean ;
Carroll, Susan ;
Balser, John ;
Balser, Barbara ;
Horwitz, Steven .
JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (06) :631-636
[2]   A Phase II trial of Belinostat (PXD101) in patients with relapsed or refractory peripheral or cutaneous T-cell lymphoma [J].
Foss, Francine ;
Advani, Ranjana ;
Duvic, Madeleine ;
Hymes, Kenneth B. ;
Intragumtornchai, Tanin ;
Lekhakula, Arnuparp ;
Shpilberg, Ofer ;
Lerner, Adam ;
Belt, Robert J. ;
Jacobsen, Eric D. ;
Laurent, Guy ;
Ben-Yehuda, Dina ;
Beylot-Barry, Marie ;
Hillen, Uwe ;
Knoblauch, Poul ;
Bhat, Gajanan ;
Chawla, Shanta ;
Allen, Lee F. ;
Pohlman, Brad .
BRITISH JOURNAL OF HAEMATOLOGY, 2015, 168 (06) :811-819
[3]   Small-molecule inhibition of proteasome and aggresome function induces synergistic antitumor activity in multiple myeloma [J].
Hideshima, T ;
Bradner, JE ;
Wong, J ;
Chauhan, D ;
Richardson, P ;
Schreiber, SL ;
Anderson, KC .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (24) :8567-8572
[4]   Objective responses in relapsed T-cell lymphomas with single-agent brentuximab vedotin [J].
Horwitz, Steven M. ;
Advani, Ranjana H. ;
Bartlett, Nancy L. ;
Jacobsen, Eric D. ;
Sharman, Jeff P. ;
O'Connor, Owen A. ;
Siddiqi, Tanya ;
Kennedy, Dana A. ;
Oki, Yasuhiro .
BLOOD, 2014, 123 (20) :3095-3100
[5]   Survival of Patients With Peripheral T-Cell Lymphoma After First Relapse or Progression: Spectrum of Disease and Rare Long-Term Survivors [J].
Mak, Vivien ;
Hamm, Jeremey ;
Chhanabhai, Mukesh ;
Shenkier, Tamara ;
Klasa, Richard ;
Sehn, Laurie H. ;
Villa, Diego ;
Gascoyne, Randy D. ;
Connors, Joseph M. ;
Savage, Kerry J. .
JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (16) :1970-+
[6]   Efficacy and mechanism of action of the proteasome inhibitor PS-341 in T-cell lymphomas and HTLV-I associated adult T-cell leukemia/lymphoma [J].
Nasr, R ;
El-Sabban, ME ;
Karam, JA ;
Dbaibo, G ;
Kfoury, Y ;
Arnulf, B ;
Lepelletier, Y ;
Bex, F ;
de Thé, H ;
Hermine, O ;
Bazarbachi, A .
ONCOGENE, 2005, 24 (03) :419-430
[7]   Pralatrexate in Patients With Relapsed or Refractory Peripheral T-Cell Lymphoma: Results From the Pivotal PROPEL Study [J].
O'Connor, Owen A. ;
Pro, Barbara ;
Pinter-Brown, Lauren ;
Bartlett, Nancy ;
Popplewell, Leslie ;
Coiffier, Bertrand ;
Lechowicz, Mary Jo ;
Savage, Kerry J. ;
Shustov, Andrei R. ;
Gisselbrecht, Christian ;
Jacobsen, Eric ;
Zinzani, Pier Luigi ;
Furman, Richard ;
Goy, Andre ;
Haioun, Corinne ;
Crump, Michael ;
Zain, Jasmine M. ;
Hsi, Eric ;
Boyd, Adam ;
Horwitz, Steven .
JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (09) :1182-1189
[8]   Treatment and prognosis of mature T-cell and NK-cell lymphoma: an analysis of patients with T-cell lymphoma treated in studies of the German High-Grade Non-Hodgkin Lymphoma Study Group [J].
Schmitz, Norbert ;
Truemper, Lorenz ;
Ziepert, Marita ;
Nickelsen, Maike ;
Ho, Anthony D. ;
Metzner, Bernd ;
Peter, Norma ;
Loeffler, Markus ;
Rosenwald, Andreas ;
Pfreundschuh, Michael .
BLOOD, 2010, 116 (18) :3418-3425
[9]  
Tan D, 2015, LANCET HAEMATOL
[10]   International peripheral T-cell and natural killer/T-cell lymphoma study: Pathology findings and clinical outcomes [J].
Vose, Julie M. ;
Neumann, M. ;
Harris, Mildred E. .
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (25) :4124-4130